Hansa Biopharma AB Statistics
Total Valuation
STO:HNSA has a market cap or net worth of SEK 4.59 billion. The enterprise value is 4.20 billion.
Important Dates
The last earnings date was Wednesday, November 11, 2026.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:HNSA has 101.76 million shares outstanding. The number of shares has increased by 40.32% in one year.
| Current Share Class | 101.76M |
| Shares Outstanding | 101.76M |
| Shares Change (YoY) | +40.32% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 6.16% |
| Owned by Institutions (%) | 24.53% |
| Float | 65.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.23 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.30 |
| P/OCF Ratio | 9.30 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 8.51 |
Financial Position
The company has a current ratio of 1.62
| Current Ratio | 1.62 |
| Quick Ratio | 1.61 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.92 |
| Interest Coverage | -3.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -27.15% |
| Return on Invested Capital (ROIC) | -117.64% |
| Return on Capital Employed (ROCE) | -60.16% |
| Weighted Average Cost of Capital (WACC) | 13.97% |
| Revenue Per Employee | 2.72M |
| Profits Per Employee | -7.25M |
| Employee Count | 131 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 28.78 |
Taxes
In the past 12 months, STO:HNSA has paid 2.15 million in taxes.
| Income Tax | 2.15M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +66.20% in the last 52 weeks. The beta is 1.68, so STO:HNSA's price volatility has been higher than the market average.
| Beta (5Y) | 1.68 |
| 52-Week Price Change | +66.20% |
| 50-Day Moving Average | 38.09 |
| 200-Day Moving Average | 34.95 |
| Relative Strength Index (RSI) | 59.18 |
| Average Volume (20 Days) | 1,021,739 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:HNSA had revenue of SEK 301.64 million and -805.23 million in losses. Loss per share was -7.91.
| Revenue | 301.64M |
| Gross Profit | 164.70M |
| Operating Income | -589.13M |
| Pretax Income | -803.08M |
| Net Income | -805.23M |
| EBITDA | -580.79M |
| EBIT | -589.13M |
| Loss Per Share | -7.91 |
Full Income Statement Balance Sheet
The company has 1.34 billion in cash and 948.28 million in debt, with a net cash position of 388.90 million or 3.82 per share.
| Cash & Cash Equivalents | 1.34B |
| Total Debt | 948.28M |
| Net Cash | 388.90M |
| Net Cash Per Share | 3.82 |
| Equity (Book Value) | -685.44M |
| Book Value Per Share | -6.74 |
| Working Capital | 587.61M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 494.07 million and capital expenditures -127,000, giving a free cash flow of 493.94 million.
| Operating Cash Flow | 494.07M |
| Capital Expenditures | -127,000 |
| Depreciation & Amortization | 8.97M |
| Net Borrowing | -32.67M |
| Free Cash Flow | 493.94M |
| FCF Per Share | 4.85 |
Full Cash Flow Statement Margins
Gross margin is 54.60%, with operating and profit margins of -195.31% and -266.95%.
| Gross Margin | 54.60% |
| Operating Margin | -195.31% |
| Pretax Margin | -266.24% |
| Profit Margin | -266.95% |
| EBITDA Margin | -192.54% |
| EBIT Margin | -195.31% |
| FCF Margin | 163.75% |
Dividends & Yields
STO:HNSA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -40.32% |
| Shareholder Yield | -40.32% |
| Earnings Yield | -17.52% |
| FCF Yield | 10.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Analyst Forecast
The average price target for STO:HNSA is 72.00, which is 59.50% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 72.00 |
| Price Target Difference | 59.50% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 56.42% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |